联系客服

002907 深市 华森制药


首页 公告 华森制药:半年度非经营性资金占用及其他关联资金往来情况汇总表

华森制药:半年度非经营性资金占用及其他关联资金往来情况汇总表

公告日期:2022-08-16

华森制药:半年度非经营性资金占用及其他关联资金往来情况汇总表 PDF查看PDF原文

    2022上半年度非经营性资金占用及其他关联金往来情况汇总表

 编制单位:重庆华森制药股份有限公司                                                                      单位:万

 元

                                                        2022 上半年

                  资金占 占用方与上 上市公司核 2022 上 半 度占用累计2022上半年度 2022上半年 2022上半年

                  用方名 市公司的关 算的会计科 年期初占 发生金额(不 占 用 资 金 的 度偿还累计 期末占用资 占用形

 非经营性资金占用    称    联关系      目    用资金余 含利息)  利息(如有) 发生金额  金余额  成原因  占用性质
                                                额

控股股东、实际控制                                                                                          非经营性占
 人及其附属企业                                                                                                用

        小计        -        -        -                                                                      -

前控股股东、实际控                                                                                          非经营性占
 制人及其附属企业                                                                                              用


      小计          -        -        -                                                                      -

 其他关联方及其附                                                                                          非经营性占
    属企业                                                                                                    用

      小计          -        -        -                                                                      -

      总计          -        -        -                                                                      -

                                                        2022 上半年                                          往来性质
                  资金往 往来方与上 上市公司核 2022 上 半 度往来累计2022上半年度 2022上半年 2022上半年        (经营性往
                  来方名 市公司的关 算的会计科 年期初往 发生金额(不 往 来 资 金 的 度偿还累计 期末往来资 往来形 来、非经营性
 其他关联资金往来    称    联关系      目    来资金余 含利息)  利息(如有) 发生金额  金余额  成原因  往来)
                                                额

控股股东、实际控制
 人及其附属企业
 上市公司的子公司

  及其附属企业

 其他关联方及其附 成都奥睿药 联营企业  应收账款  0        0.13      0          0.13      0        正常业 经营性往来
    属企业      业有限公司                                                                          务往来


      总计                                    0        0.13      0          0.13      0

                    -        -        -                                                                      -

法定代表人:游洪涛                        主管会计工作的负责人:刘小英                      会计机构负责人:彭晓
                                                      燕

[点击查看PDF原文]